Related Experiment Video
Updated: Oct 16, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma
Christopher S Hong1, Mohammad Khan2, Jordan M Sukys3
1Department of Neurosurgery, Division of Otolaryngology, Yale School of Medicine, New Haven, Connecticut 06510, USA.
Abstract:
Glomangiopericytomas are rare, primary sinonasal tumors. The existing literature is mostly limited to reports describing the clinicopathologic characteristics of these tumors. Comprehensive genetic characterization of glomangiopericytomas remains lacking. Whole-exome sequencing of a case of glomangiopericytoma was performed under an institutional review board-approved protocol. A 69-yr-old female underwent surgical resection of a glomangiopericytoma. Whole-exome sequencing revealed somatic mutations in CTNNB1 and PIK3CA, the former previously associated with this pathology but the latter not described. Concurrent dysregulation of Wnt/β-catenin and PI3K/AKT/mTOR signaling, secondary to mutations in these two oncogenes, may be amenable to targeted treatment with existing clinically approved drugs. Genomic characterization of glomangiopericytomas remains lacking. This study reports novel coexistence of PIK3CA and CTNNB1 mutations in a case of glomangiopericytoma that may offer insight into the pathogenesis and potential for targeted medical therapies of this rare tumor.
Insights
This study identifies new genetic mutations, CTNNB1 and PIK3CA, in a rare sinonasal tumor called glomangiopericytoma. These findings may lead to targeted therapies for this uncommon cancer.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Glomangiopericytomas are rare sinonasal tumors with limited genetic characterization.
- Existing literature primarily focuses on clinicopathologic descriptions.
Observation:
- Whole-exome sequencing was performed on a glomangiopericytoma case.
- Somatic mutations in CTNNB1 and PIK3CA were identified.
Findings:
- This is the first report of concurrent CTNNB1 and PIK3CA mutations in glomangiopericytoma.
- CTNNB1 mutations have been previously associated with this tumor, but PIK3CA mutations are novel.
Implications:
- The identified mutations suggest dysregulation of Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways.
- These genetic alterations may present therapeutic targets for glomangiopericytoma using existing drugs.
More Related Videos
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...